Expert Explains | A daily pill that slashes cholesterol: How it works, why it’s a breakthrough
The US Food and Drug Administration (FDA) approved Lipfendra, a daily pill that can lower low-density lipoprotein (LDL) cholesterol by up to 60%. Developed by Merck, this PCSK9 inhibitor offers a new option for high-risk patients who do not adequately respond to statins, the current first-choice treatment. The approval marks a significant advancement in cholesterol management, providing a more accessible alternative to expensive injectable medications.